TIAA Trust National Association Buys 1,605 Shares of Waters Corporation $WAT

TIAA Trust National Association increased its holdings in shares of Waters Corporation (NYSE:WAT) by 161.6% in the second quarter, HoldingsChannel reports. The firm owned 2,598 shares of the medical instruments supplier’s stock after buying an additional 1,605 shares during the period. TIAA Trust National Association’s holdings in Waters were worth $907,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Zions Bancorporation National Association UT bought a new position in Waters during the first quarter worth about $28,000. IFP Advisors Inc grew its holdings in Waters by 118.9% during the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 44 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in Waters during the first quarter worth about $41,000. Creative Financial Designs Inc. ADV grew its holdings in Waters by 533.3% during the second quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after purchasing an additional 160 shares during the period. Finally, Steph & Co. bought a new position in Waters during the second quarter worth about $73,000. Institutional investors own 94.01% of the company’s stock.

Waters Trading Up 6.6%

Shares of WAT stock opened at $368.41 on Wednesday. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56. The firm has a 50 day moving average price of $319.11 and a two-hundred day moving average price of $325.09. The company has a market capitalization of $21.93 billion, a PE ratio of 33.22, a price-to-earnings-growth ratio of 3.19 and a beta of 1.04.

Waters (NYSE:WAT) last released its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company had revenue of $608.55 million during the quarter. As a group, analysts predict that Waters Corporation will post 12.86 earnings per share for the current year.

Wall Street Analyst Weigh In

WAT has been the subject of a number of research analyst reports. Rothschild Redb upgraded Waters to a “strong-buy” rating in a report on Wednesday, October 8th. Wells Fargo & Company reduced their price target on Waters from $330.00 to $315.00 and set an “equal weight” rating for the company in a report on Tuesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Waters in a research report on Wednesday, October 8th. UBS Group restated a “neutral” rating on shares of Waters in a research report on Tuesday, July 15th. Finally, Rothschild & Co Redburn assumed coverage on shares of Waters in a research report on Wednesday, October 8th. They set a “buy” rating and a $390.00 price objective for the company. Two research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $375.54.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.